Spire Wealth Management Arcturus Therapeutics Holdings Inc. Transaction History
Spire Wealth Management
- $2.7 Billion
- Q2 2025
A detailed history of Spire Wealth Management transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Spire Wealth Management holds 9,955 shares of ARCT stock, worth $118,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,955
Previous 5,655
76.04%
Holding current value
$118,564
Previous $59,000
118.64%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARCT
# of Institutions
160Shares Held
25.8MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$55.9 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$31.6 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$22.9 Million0.27% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$21.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$20.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $317M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...